Open trial of flutamide for treatment of obsessive-compulsive disorder.
Journal of Clinical Psychiatry.
Times cited: 19
Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients.
Times cited: 28